Novartis AG

US · NVS #65 by market cap Listed 1970

150.20 -0.42 -0.28%

Live - 5344 symbols - heartbeat 541s ago · 2026-10-20 08:17

✦ Quant Ownership Signal how this is computed

Accumulating

The number of reporting institutions decreased by 14 in the most recent period (2026/Q3).
Total institutional ownership rose 0.2 percentage points.

Institutional ownership

Held by institutions: 38.57% +0.18pp
Institutions: 2,344 -14
As of: 2026/Q3 vs. prior period

Ownership vs. money flow

Diverging

Institutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund31.02%

Private Company2.65%

Sovereign Wealth Fund2.42%

Government Pension Fund0.95%

Public Company0.80%

Hedge Fund0.34%

Insurance Company0.22%

Family Office/Trust0.12%

Individual/Insider0.11%

Other61.37%

Top holders as of 2026-07-31

UBS Asset Management 5.02% · 95.37M sh

Vanguard Capital Management, LLC 4.09% · 77.67M sh

Norges Bank Investment Management 2.42% · 45.95M sh

Sandoz Family Office SA 2.22% · 42.25M sh

Geode Capital Management, LLC 0.94% · 17.86M sh

Other 84.18%

GQG Partners, LLC 0.88% · 16.78M sh

Fisher Investments 0.86% · 16.35M sh

MFS Investment Management 0.80% · 15.19M sh

Deutsche Asset & Wealth Management 0.69% · 13.13M sh

Artisan Partners Limited Partnership 0.69% · 13.07M sh

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

2 filings tracked · 0 buys · 2 sells

Name	Role	Stake
Aharon Gal	Chief Strategy & Growth Officer	0.00%
Robert Kowalski	Chief People & Organization Officer	0.00%

Insider transactions most recent Form 4 filings

Date	Name	Role	Type	Shares	Price
2024-08-11	Robert Kowalski	Chief People & Organization Officer	Intent to Sell (Form 144)	-6,566	$111.72
2024-05-21	Aharon Gal	Chief Strategy & Growth Officer	Intent to Sell (Form 144)	-2,500	$101.93

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-20 08:17:48 · For reference only, not investment advice and not tailored to your situation.